Motonobu Nishimura

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy

Masaki Fujimoto, Yoshiro Maezawa, Koutaro Yokote et al. · Biochemical and Biophysical Research Communications · 2003 · 188 citations

Medicine, Nephrology, Pathobiology +12

Enhanced Expression of Osteopontin in Human Diabetic Artery and Analysis of Its Functional Role in Accelerated Atherogenesis

Minoru Takemoto, Koutaro Yokote, Motonobu Nishimura et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 111 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Purification and Characterization of a Novel Xylulose 5-Phosphate-activated Protein Phosphatase Catalyzing Dephosphorylation of Fructose-6-phosphate,2-kinase:Fructose-2,6-bisphosphatase

Motonobu Nishimura, Kosaku Uyeda · Journal of Biological Chemistry · 1995 · 102 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration

Suguru Shiraya, Takashi Miyake, Motokuni Aoki et al. · Atherosclerosis · 2008 · 96 citations

Medicine, Immunology, Pharmacology +15